KARPOS – A Phase 1, Single-Centre, Non-randomised, Open-labelled, Escalating Dose Study of Autologous GD2-Specific Chimeric Antigen Receptor-expressing Peripheral Blood T cells in Patients with Recurrent GD2-positive Glioblastoma Multiforme
ACTRN 12622001514796 Brief Summary The aim of this study is to assess…
Read more arrow_forward